Glucotrack, Inc. (GCTK) Form 8-K — Jul 15, 2026
$GCTKForm 8-KItems 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01Filed Jul 15, 2026, 5:20 PM ET0001493152-26-033393Original filing
Glucotrack, Inc. completed a reverse merger with Lokahi Therapeutics, Inc. on July 14, 2026, resulting in Lokahi stockholders owning 90% of the combined company on a fully diluted basis. The transaction included the appointment of Erik Emerson as Chief Executive Officer and Paul V.
Key figures
- Debt Amount
- 4.45 million
- Interest Rate
- 8%
- Gross Proceeds
- 4.45 million
- Eloc capacity
- 50 million
- Commitment fee
- 1 million
- Pipe capacity max
- 30 million
- Pipe capacity min
- 10 million
- Bridge financing oid
- 22%
- Subsidiary contribution
- 7 million
- Commitment warrant value
- 10 million
- Bridge financing maturity
- 9 months
- Existing stockholder floor percent
- 10%
- Lokahi stockholder allocation percent
- 90%
Price after filing
1 day: -5.5%7 days: -42.2%30 days: -30.9%
Close on the filing date to close N calendar days later (from $0.53). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.